Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
about
Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM studyVaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.Vaginal progesterone to prevent preterm birth in pregnant women with a sonographic short cervix: clinical and public health implications.Vaginal Progesterone for Preventing Preterm Birth and Adverse Perinatal Outcomes in Singleton Gestations with a Short Cervix: A Meta-Analysis of Individual Patient Data.Choice of Outcome Measure in an Economic Evaluation: A Potential Role for the Capability Approach.
P2860
Cost and cost effectiveness of vaginal progesterone gel in reducing preterm birth: an economic analysis of the PREGNANT trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@en
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@nl
type
label
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@en
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@nl
prefLabel
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@en
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@nl
P2093
P2860
P1433
P1476
Cost and cost effectiveness of ...... nalysis of the PREGNANT trial.
@en
P2093
Eric Jutkowitz
Jason K Baxter
Laura T Pizzi
Neil S Seligman
P2860
P2888
P304
P356
10.1007/S40273-014-0133-2
P577
2014-05-01T00:00:00Z